Please ensure Javascript is enabled for purposes of website accessibility

Why Livongo Health and Teladoc Health Stocks Are Tumbling Today

By Keith Speights – Updated Aug 24, 2020 at 12:17PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An analyst's downgrade for one of these stocks caused the other to fall, too.

What happened

Shares of Livongo Health (LVGO) were tumbling 5.2% lower as of 11:25 a.m. EDT on Monday while shares of Teladoc Health (TDOC -3.40%) were down 6.3%. The declines came after Stifel analyst David Grossman downgraded Livongo from a buy recommendation to a hold.

So what

Since Teladoc and Livongo announced plans to merge earlier this month, the two healthcare stocks have been joined at the hip. When one goes down, the other marches in lockstep. It makes sense, therefore, that bad news for Livongo would also negatively impact Teladoc.

Person holding smart phone displaying blood sugar level

Image source: Getty Images.

However, the news in this case doesn't really seem to be all that bad. Stifel already had a hold recommendation for Teladoc. It's not surprising at all that the firm would change its recommendation of Livongo to be the same. Also, David Grossman kept his price target for Livongo at $137. After today's decline, the stock is below that level.

Analysts' downgrades should be taken with a grain of salt, though. Wall Street analysts typically focus more on the short term than the long term. The long-term prospects for Livongo and Teladoc appear to be strong.

Now what

The Teladoc-Livongo merger is expected to close later this year. Both companies should report quarterly updates before then. With the COVID-19 pandemic driving increased demand for telehealth and remote chronic disease management, don't be surprised if the pullback for these two stocks is relatively short-lived.

Keith Speights owns shares of Livongo Health Inc and Teladoc Health. The Motley Fool owns shares of and recommends Livongo Health Inc and Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$27.60 (-3.40%) $0.97
Livongo Health Inc Stock Quote
Livongo Health Inc

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.